Dibenzofuran

Dibenzofuran

SCHEMBL367550

c1ccc2c(c1)oc1ccccc12.c1ccc2c(c1)sc1ccccc12

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.67
MAPT P10636 6/20 0.50
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 5/20 0.50
HPGD P15428 4/20 0.50
MAOA P21397 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
GLA P06280 1/20 0.50
CYP3A4 P08684 1/20 0.50
PGAM1 P18669 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
AHR P35869 3/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 2/20 0.47
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dibenzofuran SCHEMBL11694595 0.94 GPR3 (0.58) GPR3MAPTALDH1A1KDM4EHPGD
SCHEMBL17253745 0.87 AHR (0.50) GPR3MAPTALDH1A1KDM4EHPGD
Dibenzofuran SCHEMBL28351842 0.87 GPR3 (0.50) GPR3MAPTALDH1A1KDM4EHPGD
SCHEMBL17930625 0.87 AHR (0.50) GPR3MAPTALDH1A1KDM4EHPGD
SCHEMBL15836095 0.84 MAPT (0.47) GPR3MAPTALDH1A1KDM4EHPGD
SCHEMBL20277487 0.84 MAPT (0.47) GPR3MAPTALDH1A1KDM4EHPGD
SCHEMBL18597136 0.84 MAPT (0.47) GPR3MAPTALDH1A1KDM4EHPGD
SCHEMBL20706801 0.84 MAPT (0.47) GPR3MAPTALDH1A1KDM4EHPGD
SCHEMBL20706688 0.84 MAPT (0.47) GPR3MAPTALDH1A1KDM4EHPGD
SCHEMBL17431203 0.84 AHR (0.47) GPR3MAPTALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107857769-A Heterocyclic compound and organic light-emitting element comprising same 株式会社LG化学 2018-03-30 CN claimed
US-9663544-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2017-05-30 US claimed
CN-117501857-A Organic electronic device comprising compound of formula (1), display apparatus comprising the same, and compound of formula (1) for use in organic electronic device 诺瓦尔德股份有限公司 2024-02-02 CN disclosed
US-20230389414-A1 ORGANIC COMPOUNDS AND USES THEREOF IN ORGANIC ELETRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-30 US disclosed
US-20230380280-A1 ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-23 US disclosed
US-20230357169-A1 ORGANIC COMPOUNDS, MIXTURES, AND USES THEREOF IN ORGANIC ELETRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
CN-116855408-A Sphingomonas cornfield and application thereof in ascr#18 decomposition 广东省科学院动物研究所 2023-10-10 CN disclosed
CN-115551865-A Organic compound, light-emitting device, light-emitting apparatus, electronic device, display apparatus, and lighting apparatus 株式会社半导体能源研究所 2022-12-30 CN disclosed
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2021-11-16 US disclosed
EP-3906246-A1 MONONUCLEAR IRIDIUM COMPLEXES CONTAINING THREE ORTHO-METALLATED BIDENTATE LIGANDS AND OPTICAL ORIENTATING ANISTROPHY Merck Patent GmbH (DE) 2021-11-10 EP disclosed
US-20210280799-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-09-09 US disclosed
US-9190623-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2015-11-17 US disclosed
US-20140138627-A1 Organic Electroluminescent Device With Delayed Fluorescence UNIVERSAL DISPLAY CORPORATION (US) 2014-05-22 US disclosed
US-20120012821-A1 SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2012-01-19 US disclosed
EP-1227721-A4 NOVEL SUBSTITUTED SUCCINIC ACID METALLO-BETA-LACTAMASE INHIBITORS AND THEIR USE IN TREATING BACTERIAL INFECTIONS MERCK & CO INC (US) 2004-09-22 EP disclosed
EP-1227722-A1 NOVEL SUCCINIC ACID METALLO-BETA-LACTAMASE INHIBITORS AND THEIR USE IN TREATING BACTERIAL INFECTIONS Merck & Co., Inc. (US) 2002-08-07 EP disclosed
EP-1227721-A1 NOVEL SUBSTITUTED SUCCINIC ACID METALLO-BETA-LACTAMASE INHIBITORS AND THEIR USE IN TREATING BACTERIAL INFECTIONS Merck & Co., Inc. (US) 2002-08-07 EP disclosed
WO-2001030149-A1 NOVEL SUCCINIC ACID METALLO-BETA-LACTAMASE INHIBITORS AND THEIR USE IN TREATING BACTERIAL INFECTIONS MERCK & CO., INC. (US) 2001-05-03 WO disclosed
WO-2001030148-A1 NOVEL SUBSTITUTED SUCCINIC ACID METALLO-BETA-LACTAMASE INHIBITORS AND THEIR USE IN TREATING BACTERIAL INFECTIONS MERCK & CO., INC. (US) 2001-05-03 WO disclosed
US-5330900-A Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes TROPIX, INC. (US) 1994-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357169-A1 ORGANIC COMPOUNDS, MIXTURES, AND USES THEREOF IN ORGANIC ELETRONIC DEVICES SLCO1B3, SLCO2B1, SLCO2A1 GPR3 3694/4885MAPT 1108/4885ALDH1A1 389/4885
US-20210280799-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, DRD1 GPR3 793/4885MAPT 3616/4885ALDH1A1 421/4885
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes KCNH2, KCNH3, KCNJ2 GPR3 1455/4885MAPT 2580/4885ALDH1A1 397/4885
US-20230389414-A1 ORGANIC COMPOUNDS AND USES THEREOF IN ORGANIC ELETRONIC DEVICES SLCO2B1, SLCO2A1, SLCO1B3 GPR3 3775/4885MAPT 1343/4885ALDH1A1 245/4885
US-20230380280-A1 ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES OR10J3, AOX1, SLCO4C1 GPR3 2958/4885MAPT 1171/4885ALDH1A1 338/4885
US-20120012821-A1 SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS DDT, CDKL1, CDK2 GPR3 1523/4885MAPT 1784/4885ALDH1A1 750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.